Critical Care

official impact factor 4.60

This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Highly Access

Gram-negative antibiotic resistance: there is a price to pay

Thomas G Slama

Critical Care 2008, 12(Suppl 4):S4 doi:10.1186/cc6820

Accesses  

  • Last 30 days: 153 accesses
  • Last 365 days: 2249 accesses
  • All time: 13982 accesses